PARP inhibitors for anticancer therapy
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2014 |
|---|---|
| Erschienen: |
2014 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:42 |
|---|---|
| Enthalten in: |
Biochemical Society transactions - 42(2014), 1, Seite 82-88 |
| Beteiligte Personen: |
Curtin, Nicola [VerfasserIn] |
|---|
| Umfang: |
7 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
OLC1935293656 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC1935293656 | ||
| 003 | DE-627 | ||
| 005 | 20230714055527.0 | ||
| 007 | tu | ||
| 008 | 140127s2014 xx ||||| 00| ||und c | ||
| 028 | 5 | 2 | |a sw140124_1 |
| 035 | |a (DE-627)OLC1935293656 | ||
| 035 | |a (DE-599)GBVOLC1935293656 | ||
| 035 | |a (KEY)0029353920140000042000100082parpinhibitorsforanticancertherapy | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 082 | 0 | 4 | |a 570 |a 540 |
| 100 | 1 | |a Curtin, Nicola |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a PARP inhibitors for anticancer therapy |
| 264 | 1 | |c 2014 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 773 | 0 | 8 | |i Enthalten in |t Biochemical Society transactions |d London : Portland Press, 1973 |g 42(2014), 1, Seite 82-88 |w (DE-627)129387398 |w (DE-600)184237-7 |w (DE-576)014773813 |x 0300-5127 |7 nnns |
| 773 | 1 | 8 | |g volume:42 |g year:2014 |g number:1 |g pages:82-88 |g extent:7 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-CHE | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a GBV_ILN_70 | ||
| 912 | |a GBV_ILN_2010 | ||
| 912 | |a GBV_ILN_2011 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4125 | ||
| 912 | |a GBV_ILN_4219 | ||
| 951 | |a AR | ||
| 952 | |d 42 |j 2014 |e 1 |h 82-88 |g 7 | ||